|Articles|May 20, 2020
ERT Announces Virtual Visit Capabilities
Advertisement
ERT has announced a Virtual Visit solution that enables the continuation of clinical trials during and after current global stay-at-home mandates due to the COVID-19 outbreak. ERT’s Virtual Visit solution enables at-home consultations between patients and investigative site personnel via a dedicated, secure app or web interface.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials in 2026: Platformization, AI Fluency, and the Redrawing of the Value Chain
2
Moving Beyond Historical Site Data to Real-Time Patient Insight
3
How Community Sites Can Stay Competitive Under Growing Efficiency Pressures
4
ACT Brief: Community Sites Compete on Readiness, COA Licensing Bottlenecks Slow Start-Up, and AI’s Foundations in Pharmacovigilance
5